FBXO32 and Atrophy: NF-κB and its downstream pathways play a pivotal role in the pathogenesis of muscle atrophy by enhancing inflammation, increasing muscle-specific E3 ubiquitin ligases, such as muscle RING finger-1 (MuRF1) and atrogin-1/MAFbx, and inhibiting myogenesis [7].